139 related articles for article (PubMed ID: 8874364)
1. Safety of first trimester exposure to H2 blockers.
Lagace E
J Fam Pract; 1996 Oct; 43(4):342-3. PubMed ID: 8874364
[No Abstract] [Full Text] [Related]
2. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
[TBL] [Abstract][Full Text] [Related]
3. Outcome of pregnancy after first trimester exposure to H2 receptor antagonists.
Koren G; Zemlickis DM
Am J Perinatol; 1991 Jan; 8(1):37-8. PubMed ID: 1670987
[TBL] [Abstract][Full Text] [Related]
4. Acid-suppressing drugs during pregnancy.
Lalkin A; Magee L; Addis A; Loebstein R; Koren G
Can Fam Physician; 1997 Nov; 43():1923-4, 1927. PubMed ID: 9386876
[No Abstract] [Full Text] [Related]
5. The safety of H(2)-blockers use during pregnancy.
Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Uziel E; Levy A
J Clin Pharmacol; 2010 Jan; 50(1):81-7. PubMed ID: 19789371
[TBL] [Abstract][Full Text] [Related]
6. Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study.
Magee LA; Inocencion G; Kamboj L; Rosetti F; Koren G
Dig Dis Sci; 1996 Jun; 41(6):1145-9. PubMed ID: 8654145
[TBL] [Abstract][Full Text] [Related]
7. First-trimester exposure to alprazolam.
St Clair SM; Schirmer RG
Obstet Gynecol; 1992 Nov; 80(5):843-6. PubMed ID: 1407925
[TBL] [Abstract][Full Text] [Related]
8. Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole.
Källén B
Br J Obstet Gynaecol; 1998 Aug; 105(8):877-81. PubMed ID: 9746381
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium periconceptional exposure: pregnancy and neonatal outcome.
De Santis M; Straface G; Cavaliere AF; Carducci B; Caruso A
Acta Obstet Gynecol Scand; 2007; 86(1):99-101. PubMed ID: 17230297
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis.
Seto A; Einarson T; Koren G
Am J Perinatol; 1997 Mar; 14(3):119-24. PubMed ID: 9259911
[TBL] [Abstract][Full Text] [Related]
11. The safety of cetirizine during pregnancy. A prospective observational cohort study.
Weber-Schoendorfer C; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
Cooper WO
J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
[TBL] [Abstract][Full Text] [Related]
13. First trimester diclofenac exposure and pregnancy outcome.
Cassina M; De Santis M; Cesari E; van Eijkeren M; Berkovitch M; Eleftheriou G; Raffagnato F; Di Gianantonio E; Clementi M
Reprod Toxicol; 2010 Nov; 30(3):401-4. PubMed ID: 20438830
[TBL] [Abstract][Full Text] [Related]
14. Prenatal exposure to salicylates and gastroschisis: a case-control study.
Martínez-Frías ML; Rodríguez-Pinilla E; Prieto L
Teratology; 1997 Oct; 56(4):241-3. PubMed ID: 9408974
[TBL] [Abstract][Full Text] [Related]
15. Safety of first-trimester exposure to topical tretinoin: prospective cohort study.
Shapiro L; Pastuszak A; Curto G; Koren G
Lancet; 1997 Oct; 350(9085):1143-4. PubMed ID: 9343507
[No Abstract] [Full Text] [Related]
16. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
[TBL] [Abstract][Full Text] [Related]
17. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
[TBL] [Abstract][Full Text] [Related]
18. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
[TBL] [Abstract][Full Text] [Related]
19. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
Park-Wyllie L; Mazzotta P; Pastuszak A; Moretti ME; Beique L; Hunnisett L; Friesen MH; Jacobson S; Kasapinovic S; Chang D; Diav-Citrin O; Chitayat D; Nulman I; Einarson TR; Koren G
Teratology; 2000 Dec; 62(6):385-92. PubMed ID: 11091360
[TBL] [Abstract][Full Text] [Related]
20. Congenital malformations in the progenies of Iranian chemical victims.
Pour-Jafari H
Vet Hum Toxicol; 1994 Dec; 36(6):562-3. PubMed ID: 7900280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
